Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] ALL
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6192 6193 6194 6195 6196 6197 6198 6199 6200 6201 6202 6203 6204 6205 6206 6207 6208 6209 6210 6211 6212 6213 6214 6215 6216 6217 6218 6219 6220 6221 6222 6223 6224 6225 6226 6227 6228 6229 6230 6231 6232 … 6476 6477 6478 6479 6480 6481 6482 6483 6484 6485 6486 6487 6488 6489 6490 6491 6492 6493 6494 6495 Next Last
#
NCTID/Status
Study
Last Changed
310551
NCT00129610
Unknown status
Unknown status
Study of Virtual Reality Therapy and Cognitive Behavior Therapy in Panic Disorder With Agoraphobia
Conditions: Panic Disorder; Agoraphobia
Conditions: Panic Disorder; Agoraphobia
April 26, 2007
310552
NCT00129597
Unknown status
Unknown status
Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy
Conditions: Pain; Breast Cancer
Intervention: Ketalar
Conditions: Pain; Breast Cancer
Intervention: Ketalar
March 9, 2007
310553
NCT00129584
Completed
Completed
Endobronchial Valve for Emphysema Palliation Trial (VENT)
Conditions: Chronic Obstructive Pulmonary Disease; Emphysema
Intervention: Emphasys Endobronchial Valve And Procedure
Conditions: Chronic Obstructive Pulmonary Disease; Emphysema
Intervention: Emphasys Endobronchial Valve And Procedure
August 14, 2009
310554
NCT00129571
Completed
Completed
June 2, 2008
310555
NCT00129558
Withdrawn
Withdrawn
A Study to Evaluate PT-523 in Patients With Refractory Leukemia
Conditions: Leukemia
Intervention: PT-523 For Injection
Conditions: Leukemia
Intervention: PT-523 For Injection
December 2, 2013
310556
NCT00129545
Completed
Completed
WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation
Conditions: Atrial Fibrillation; Stroke
Intervention: WATCHMAN Left Atrial Appendage Closure Technology, Warfarin
Conditions: Atrial Fibrillation; Stroke
Intervention: WATCHMAN Left Atrial Appendage Closure Technology, Warfarin
April 29, 2015
310557
NCT00129532
Unknown status
Unknown status
Trial of SAVVY and HIV in Ghana
Conditions: HIV Infections
Conditions: HIV Infections
September 7, 2005
310558
NCT00129519
Completed
Completed
A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence
Conditions: Basal Cell Carcinoma
Intervention: Imiquimod 5% Cream
Conditions: Basal Cell Carcinoma
Intervention: Imiquimod 5% Cream
July 14, 2010
310559
NCT00129506
Completed
Completed
Comparing Methotrexate Followed by Misoprostol to Misoprostol Alone for Early Abortion
Conditions: Unwanted Pregnancies
Intervention: Methotrexate + Misoprostol, Misoprostol
Conditions: Unwanted Pregnancies
Intervention: Methotrexate + Misoprostol, Misoprostol
June 7, 2018
310560
NCT00129493
Completed
Completed
Group Visits to Improve Hypertension Management
Conditions: Hypertension
Intervention: Group Medical Visits
Conditions: Hypertension
Intervention: Group Medical Visits
April 6, 2015
310561
NCT00129480
Completed
Completed
Improving Chronic Pain Treatment in Primary Care
Conditions: Pain; Chronic Disease; Depression
Intervention: Assistance With Pain Treatment
Conditions: Pain; Chronic Disease; Depression
Intervention: Assistance With Pain Treatment
January 18, 2019
310562
NCT00129467
Completed
Completed
Methylphenidate for Depressed Cancer Patients Receiving Palliative Care
Conditions: Depression; Palliative Care; Cancer; Mental Disorder
Intervention: Methylphenidate, Placebo, Selective Serotonin Uptake Inhibitor (SSRI)
Conditions: Depression; Palliative Care; Cancer; Mental Disorder
Intervention: Methylphenidate, Placebo, Selective Serotonin Uptake Inhibitor (SSRI)
April 6, 2015
310563
NCT00129454
Completed
Completed
Telemedicine Treatment for Veterans With Gulf War Illness
Conditions: Gulf War Syndrome
Intervention: Cognitive Behavioral Therapy, Cognitive Behavioral Therapy
Conditions: Gulf War Syndrome
Intervention: Cognitive Behavioral Therapy, Cognitive Behavioral Therapy
June 2, 2017
310564
NCT00129441
Completed
Completed
Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study
Conditions: Schizophrenia
Intervention: Merck L-830982, Placebo
Conditions: Schizophrenia
Intervention: Merck L-830982, Placebo
October 14, 2011
310565
NCT00129428
Completed
Completed
Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix
Conditions: Keloid; Scleroderma, Localized; Acne Keloidalis; Scars; Granuloma Annulare
Intervention: UVB Irradiation
Conditions: Keloid; Scleroderma, Localized; Acne Keloidalis; Scars; Granuloma Annulare
Intervention: UVB Irradiation
April 30, 2015
310566
NCT00129415
Terminated
Terminated
Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions
Conditions: Atopic Dermatitis; Psoriasis; Alopecia; Mycosis Fungoides; Urticaria; Dermatoses; Stretch Marks
Intervention: UVA1 Irradiation, UVB Irradiation
Conditions: Atopic Dermatitis; Psoriasis; Alopecia; Mycosis Fungoides; Urticaria; Dermatoses; Stretch Marks
Intervention: UVA1 Irradiation, UVB Irradiation
May 21, 2015
310567
NCT00129402
Completed
Completed
Effects of Ezetimibe With Simvastatin in the Therapy of Adolescents With HeFH (Study P02579)
Conditions: Hypercholesterolemia
Intervention: Ezetimibe With Simvastatin, Simvastatin
Conditions: Hypercholesterolemia
Intervention: Ezetimibe With Simvastatin, Simvastatin
September 2, 2015
310568
NCT00129389
Completed
Completed
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
Conditions: Breast Cancer
Intervention: Fluorouracil, Doxorubicin, Cyclophosphamide, Paclitaxel
Conditions: Breast Cancer
Intervention: Fluorouracil, Doxorubicin, Cyclophosphamide, Paclitaxel
April 26, 2019
310569
NCT00129376
Completed
Completed
Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients
Conditions: Breast Cancer
Intervention: Doxorubicin, Cyclophosphamide, Docetaxel
Conditions: Breast Cancer
Intervention: Doxorubicin, Cyclophosphamide, Docetaxel
April 12, 2019
310570
NCT00129363
Completed
Completed
Study to Evaluate the Safety of Twice Daily Oral Carvedilol
Conditions: Congestive Heart Failure
Intervention: Carvedilol
Conditions: Congestive Heart Failure
Intervention: Carvedilol
December 24, 2008
310571
NCT00129350
Unknown status
Unknown status
Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
Conditions: Emphysema; Alveolitis, Fibrosing; Cystic Fibrosis; Bronchiectasis; Lung Diseases
Conditions: Emphysema; Alveolitis, Fibrosing; Cystic Fibrosis; Bronchiectasis; Lung Diseases
September 6, 2005
310572
NCT00129337
Completed
Completed
Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies
Conditions: Tumors
Intervention: Bavituximab
Conditions: Tumors
Intervention: Bavituximab
February 28, 2011
310573
NCT00129324
Enrolling by invitation
Enrolling by invitation
HOME Study (Health Outcomes and Measures of the Environment Study)
Conditions: Environmental Exposures; Child Development; Lead and Injury Reduction
Intervention: Lead Hazard Control Intervention, Injury Hazard Control Intervention
Conditions: Environmental Exposures; Child Development; Lead and Injury Reduction
Intervention: Lead Hazard Control Intervention, Injury Hazard Control Intervention
February 15, 2019
310574
NCT00129311
Completed
Completed
Usefulness of Selegiline as an Aid to Quit Smoking - 1
Conditions: Tobacco Use Cessation
Intervention: Selegiline, Placebo
Conditions: Tobacco Use Cessation
Intervention: Selegiline, Placebo
March 11, 2015
310575
NCT00129298
Completed
Completed
Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1
Conditions: Cocaine-Related Disorders; Opiate Dependence
Intervention: Tiagabine
Conditions: Cocaine-Related Disorders; Opiate Dependence
Intervention: Tiagabine
January 11, 2017
310576
NCT00129285
Completed
Completed
Modafinil Treatment for Cocaine-Dependent Individuals
Conditions: Cocaine-Related Disorders
Intervention: Low Dose Modafinil, High Dose Modafinil, Placebo
Conditions: Cocaine-Related Disorders
Intervention: Low Dose Modafinil, High Dose Modafinil, Placebo
April 5, 2018
310577
NCT00129272
Completed
Completed
Effectiveness of Bupropion for Treating Nicotine Dependence in Young People
Conditions: Tobacco Use Cessation; Tobacco Use Disorder
Intervention: Bupropion-SR, Placebo
Conditions: Tobacco Use Cessation; Tobacco Use Disorder
Intervention: Bupropion-SR, Placebo
April 17, 2017
310578
NCT00129259
Completed
Completed
Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1
Intervention: Anti-CD3 MAb, Diabetes Standard Of Care Treatment, Iron Supplementation
Conditions: Diabetes Mellitus, Type 1
Intervention: Anti-CD3 MAb, Diabetes Standard Of Care Treatment, Iron Supplementation
April 11, 2017
310579
NCT00129246
Completed
Completed
Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain
Conditions: Smoking; Nicotine Dependence
Intervention: Naltrexone, Bupropion
Conditions: Smoking; Nicotine Dependence
Intervention: Naltrexone, Bupropion
January 2, 2013
310580
NCT00129233
Completed
Completed
Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance
Conditions: Hypertension; Type 2 Diabetes Mellitus
Intervention: Valsartan, Amlodipine
Conditions: Hypertension; Type 2 Diabetes Mellitus
Intervention: Valsartan, Amlodipine
April 29, 2013
310581
NCT00129220
Completed
Completed
Trial of Olanzapine in Patients With Manic or Mixed Episode of Bipolar I Disorder
Conditions: Bipolar Disorder
Intervention: Olanzapine, Haloperidol, Placebo
Conditions: Bipolar Disorder
Intervention: Olanzapine, Haloperidol, Placebo
December 10, 2010
310582
NCT00129207
Completed
Completed
Ketoconazole Administration: How it is Affected by the Body and Broken Down and How it Acts on the Body When Used With Velcade
Conditions: Tumors
Intervention: Bortezomib
Conditions: Tumors
Intervention: Bortezomib
February 7, 2008
310583
NCT00129194
Completed
Completed
Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens
Conditions: HIV Infections
Intervention: KP-1461
Conditions: HIV Infections
Intervention: KP-1461
December 30, 2007
310584
NCT00129181
Completed
Completed
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
Conditions: Parkinson Disease; Parkinsonian Syndrome
Intervention: Cabergoline, Carbidopa/levodopa, DATscan And SPECT Imaging
Conditions: Parkinson Disease; Parkinsonian Syndrome
Intervention: Cabergoline, Carbidopa/levodopa, DATscan And SPECT Imaging
August 27, 2009
310585
NCT00129168
Completed
Completed
Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)
Conditions: Leukemia, Myeloid
Intervention: Zosuquidar, Daunorubicin, Cytarabine
Conditions: Leukemia, Myeloid
Intervention: Zosuquidar, Daunorubicin, Cytarabine
March 28, 2008
310586
NCT00129155
Unknown status
Unknown status
MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
Conditions: Hematological Malignancies; Allogeneic Transplantation
Intervention: Treosulfan
Conditions: Hematological Malignancies; Allogeneic Transplantation
Intervention: Treosulfan
October 3, 2007
310587
NCT00129142
Completed
Completed
Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
Conditions: Prostate Cancer; Osteoporosis; Fractures
Intervention: Toremifene Citrate
Conditions: Prostate Cancer; Osteoporosis; Fractures
Intervention: Toremifene Citrate
November 13, 2013
310588
NCT00129129
Completed
Completed
Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine
Conditions: Haemophilus Influenzae Type b; Neisseria Meningitidis
Intervention: GSK Biologicals' Haemophilus Influenza Type B And Neisseria Meningitidis Serogroups C And Y-tetanus Toxoid Conjugate Vaccine 792014 Vaccine, ActHIB, Pediarix, Prevnar, Menomune
Conditions: Haemophilus Influenzae Type b; Neisseria Meningitidis
Intervention: GSK Biologicals' Haemophilus Influenza Type B And Neisseria Meningitidis Serogroups C And Y-tetanus Toxoid Conjugate Vaccine 792014 Vaccine, ActHIB, Pediarix, Prevnar, Menomune
July 26, 2018
310589
NCT00129116
Completed
Completed
3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age
Conditions: Haemophilus Influenzae Type b; Neisseria Meningitidis
Intervention: Hib-MenCY-TT Vaccine, Hib-MenC-TT Vaccine, Menjugate ®, Infanrix Penta ®, Infanrix Hexa ®
Conditions: Haemophilus Influenzae Type b; Neisseria Meningitidis
Intervention: Hib-MenCY-TT Vaccine, Hib-MenC-TT Vaccine, Menjugate ®, Infanrix Penta ®, Infanrix Hexa ®
July 26, 2018
310590
NCT00129090
Unknown status
Unknown status
Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma (NHL)
Intervention: R-CHOEP 14 With 12x Rituximab
Conditions: Non-Hodgkin's Lymphoma (NHL)
Intervention: R-CHOEP 14 With 12x Rituximab
September 8, 2015
310591
NCT00129077
Completed
Completed
Does the Use of a Moisture Chamber Decrease the Incidence of Corneal Abrasions in Critically Ill Pediatric Patients?
Conditions: Eye Injuries; Critically Ill
Intervention: Plastic Wrap Over Eye & Lubrication Applied Q6 Hrs
Conditions: Eye Injuries; Critically Ill
Intervention: Plastic Wrap Over Eye & Lubrication Applied Q6 Hrs
July 9, 2007
310592
NCT00129064
Completed
Completed
Improving the Outpatient Referral Process With Electronic Communications
Conditions: Communication; Interprofessional Relations
Intervention: Electronic Referral System
Conditions: Communication; Interprofessional Relations
Intervention: Electronic Referral System
April 23, 2007
310593
NCT00129051
Completed
Completed
Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases
Conditions: Neoplasm Metastasis; Carcinoma
Intervention: Tomotherapy
Conditions: Neoplasm Metastasis; Carcinoma
Intervention: Tomotherapy
February 8, 2010
310594
NCT00129038
Completed
Completed
Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients
Conditions: Coronary Arteriosclerosis
Intervention: Modified-release Dipyridamole/aspirin, Aspirin
Conditions: Coronary Arteriosclerosis
Intervention: Modified-release Dipyridamole/aspirin, Aspirin
October 28, 2013
310595
NCT00129025
Completed
Completed
Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer
Conditions: Prostate Cancer
Intervention: Hypofractionated Radiotherapy
Conditions: Prostate Cancer
Intervention: Hypofractionated Radiotherapy
October 6, 2011
310596
NCT00129012
Completed
Completed
Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
Intervention: Tomotherapy
Conditions: Carcinoma, Non-Small-Cell Lung
Intervention: Tomotherapy
February 24, 2016
310597
NCT00128999
Completed
Completed
Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
Intervention: Intensity-Modulated Radiation Therapy
Conditions: Carcinoma, Non-Small-Cell Lung
Intervention: Intensity-Modulated Radiation Therapy
February 8, 2010
310598
NCT00128986
Completed
Completed
Study of Tomotherapy in Patients With Benign Brain Tumour
Conditions: Brain Neoplasms
Intervention: Tomotherapy
Conditions: Brain Neoplasms
Intervention: Tomotherapy
April 5, 2016
310599
NCT00128973
Recruiting
Recruiting
Evaluation of Patients With Immune Function Abnormalities
Conditions: Immune System Diseases; Chronic Granulomatous Disease (CGD); X-Linked Severe Combined Immune Deficiency (XSCID); Leukocyte Adhesion Deficiency 1 (LAD); Graft Versus Host Disease (cGvHD)
Conditions: Immune System Diseases; Chronic Granulomatous Disease (CGD); X-Linked Severe Combined Immune Deficiency (XSCID); Leukocyte Adhesion Deficiency 1 (LAD); Graft Versus Host Disease (cGvHD)
December 4, 2019
310600
NCT00128960
Completed
Completed
Quality of Life in Patients Who Have Undergone Stem Cell Transplant
Conditions: Long Term Psychological Affects on HSCT
Conditions: Long Term Psychological Affects on HSCT
December 5, 2019
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6192 6193 6194 6195 6196 6197 6198 6199 6200 6201 6202 6203 6204 6205 6206 6207 6208 6209 6210 6211 6212 6213 6214 6215 6216 6217 6218 6219 6220 6221 6222 6223 6224 6225 6226 6227 6228 6229 6230 6231 6232 … 6476 6477 6478 6479 6480 6481 6482 6483 6484 6485 6486 6487 6488 6489 6490 6491 6492 6493 6494 6495 Next Last
Last Updated
The last updated date is the most recent date when changes to a clinical trial were
submitted to ClinicalTrials.gov. There is often a delay of a few days before the
updated trial is available on the clinical trials website.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
First Received
The first received date is the date when the clinical trial was first submitted
to ClinicalTrials.gov. There is often a delay of a few days before the
trial is available on the clinical trials website.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Safety Issue
If selected, restricts search results to those studies which have
an outcome measure designated as a safety issue. Note that this is a
poor estimate of the safety of a treatment or intervention, but it is
all we have now.
Funded By
Studies are supported by one or more organizations called sponsors.
Support includes contributions of facilities, expertise, and/or financial resources.
All sponsors in the database have been assigned one of the following organization types:
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
Study Phase
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Age Group
Studies may be designed for participants of particular ages:
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Gender
Searches can be restricted to studies which accept female or male participants.
Location Terms
If you are interested in a specific city (such as Los Angeles) or facility
name (such as the Mayo Clinic), enter it as a location term. Not all studies
include this level of detail, but if they do, this will find them.
Countries and States
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state.
Study IDs
Each trial is assigned one or more identification numbers by the institute, agency,
or organization sponsoring the trial. In addition, clinical trials assigns a
unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit.
Use this box to search for a trial by NCT identifier or any other study
identification numbers.
Examples:
Examples:
NCT00001789
97-h-0197
ia0006
actg 076
97-h-0197
ia0006
actg 076
Sponsor (Lead)
Use this box to specify the name of an institute, organization, or company that is
conducting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators
Use this box to specify institutes, organizations, or companies that are
conducting or otherwise supporting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Outcome Measures
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Outcome measures are used to evaluate trial results. For example, an obesity treatment
might be evaluated by a measure of weight loss after 6 months. Measures can also be used
to quantify side effects, such as number of myocardial infarctions,
number of patients with heart arrhythmia, number of suicides, etc.
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Interventions
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Conditions
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Study Type
There are three types of studies available in ClinicalTrials.gov:
There are three types of studies available in ClinicalTrials.gov:
Interventional:
Observational:
Expanded Access:
Studies where individuals are assigned to receive specific interventions.
Participants may receive diagnostic, therapeutic or other types of interventions.
Assignment of the intervention may or may not be random.
Individuals are tracked and biomedical and/or health outcomes are assessed.
Observational:
Studies without an intervention.
Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals.
Participants may receive diagnostic, therapeutic, or other interventions, but the investigator
does not assign specific interventions to the participants of the study.
Expanded Access:
Records describing the procedure for obtaining an experimental drug or device for patients who
are failing on currently available treatments for their condition and also are unable to
participate in ongoing clinical trials. Expanded Access records are used to register all
types of non-protocol access to experimental treatments, including protocol exception,
single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.
Study Results
Searches can be restricted to studies with or without results.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Recruitment Status
Also known as Enrollment Status.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Search Terms
Use this box to specify general search terms found anywhere in the trial record.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help for Searching clinical trials
Help Topics:
Basic Search:
On the Basic Search page, enter a word or word(s) that you want to use to find studies.
These may include diseases, interventions, and/or locations.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
Many searches are a single term and can be performed with a few words in the
search box. But, sometimes you need more control. Click on the Advanced Search tab
(if starting a new search) or Refine Search tab (if modifying an existing search)
to show additional search fields.
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
Sponsor (Lead):
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Performs a general search in all sections of the study record, including title,
description, conditions, interventions, locations, etc. Terms in this field are
searched the same as Basic Search.
Recruitment:
Limits search results to studies that are open or closed. New volunteers may be
able to participate in open studies, but not closed studies.
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Study Results:Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Limits search results based on whether the study has results or not:
Study Type:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov.
Only a few studies have results available.Studies With Results, or
Studies Without Results
Limits search results to any of the following study types:
Conditions:
Interventional,
Observational, or
Expanded Access
Observational, or
Expanded Access
Performs a search on fields describing the diseases or conditions being studied.
Interventions:
Performs a search on fields listing the drugs or interventions being studied.
Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.
Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
Performs a search on the sponsor field of a study.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Performs a search on fields listing ID numbers.
Country/State:
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state (e.g., United States, Alabama).
Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic).
Not all studies include this level of detail, but if they do, this will find them.
Gender:
Limits search results to those studies that accept female or male participants.
Age Group:
Limits search results to those studies that include at least one of the specified age
ranges. More than one age group can be selected.
Phase:
Limits search results to studies that are labeled with at least one of the specified
phases. More than one Phase can be selected.
Funded By:
Limits search results to studies that have at least one sponsor of the specified types.
More than one sponsor type can be selected.
Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.
First Received:
Limits search results to studies that were received by clinical trials within a
specified date range. The "From" or "To" field can be left blank.
Last Updated:
Limits search results to studies that were modified within a
specified date range. The "From" or "To" field can be left blank.
Refine Search:
Searches display a list of studies found (List Results tab). If you are not content with
the search results, click on the Refine Search tab at the top of the list to modify your
search.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
When you are done making changes, click Search to display the new results.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.